Abiopharma

Burnham Holdings Strengthens Capital Structure with New $130 Million Revolving Credit Facility

ALAR DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Alarum Technologies (ALAR) Investors of Securities Class Action Lawsuit Deadline on October 5, 2026

DXC ernennt Lisa Beaudoin zum Chief Product Officer, um das produktgetriebene Wachstum voranzutreiben

Change in holdings of interested parties/officers - Isras Holdings Ltd.

Xeriants NEXBOARD™ is Raising the Bar for Sustainable Construction Materials

Net Asset Value(s)

SEGG Medias Quadrant Premieres New Oliver Bearman Content Feature Sponsored by That Prize Guy

DXC nomme Lisa Beaudoin au poste de directrice des produits afin daccélérer sa croissance en la matière

Form 8.3

PLAB Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Photronics, Inc. Securities Lawsuit - Contact Levi & Korsinsky

Riskified y Marqeta se asocian para optimizar las decisiones de autorización de los emisores de tarjetas y ayudar a reducir los rechazos injustificados

Clinical trial NCT07142655 updates: 1. completion date: 2025-10-31 → 2026-03-09 2. primary completion date: 2025-10-31 → 2026-03-09

Clinical trial NCT06577298 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07222852 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-11-15 → 2026-01-01

Clinical trial NCT04826237 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2025-12-31 → 2025-10-30 3. primary completion date: 2025-10-01 → 2025-10-30 4. enrollment: 100 → 3 participants 5. enrollment type: ESTIMATED → ACTUAL